BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30811510)

  • 1. Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya.
    de Necker M; de Beer JC; Stander MP; Connell CD; Mwai D
    PLoS One; 2019; 14(2):e0212972. PubMed ID: 30811510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.
    Qian SRW; Hassan SA; Scallon AJ; Oyaro P; Brown E; Wagude J; Mukui I; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Yongo N; Karauki E; Gao J; Otieno L; John-Stewart GC; Abuogi LL; Patel RC
    BMC Health Serv Res; 2022 Dec; 22(1):1540. PubMed ID: 36528677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    Ndlovu Z; Fajardo E; Mbofana E; Maparo T; Garone D; Metcalf C; Bygrave H; Kao K; Zinyowera S
    PLoS One; 2018; 13(3):e0193577. PubMed ID: 29499042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas).
    Patel RC; Oyaro P; Thomas KK; Basha GW; Wagude J; Mukui I; Brown E; Hassan SA; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Karauki E; Yongo N; Otieno L; John-Stewart GC; Abuogi LL
    J Int AIDS Soc; 2023 Nov; 26(11):e26182. PubMed ID: 37938856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa.
    Boeke CE; Joseph J; Atem C; Banda C; Coulibaly KD; Doi N; Gunda A; Kandulu J; Kiernan B; Kingwara L; Maokola W; Maparo T; Mbaye RN; Mtumbuka E; Mziray J; Ngugi C; Nkakulu J; Nzuobontane D; Okomo Assoumo MC; Peter T; Rioja MR; Sacks JA; Simbi R; Vojnov L; Khan SA
    J Int AIDS Soc; 2021 Jan; 24(1):e25663. PubMed ID: 33455081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
    Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
    J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for feasibility of plasma based GeneXpert platform and Dried Blood Spot (DBS) based Abbott platform for HIV-1 viral load testing among the people living with HIV attending ART centers in India.
    Kamble S; Shidhaye P; Mukherjee A; Tak M; Bembalkar S; Aggarwal S; Deb A; Kapoor N; Verma V; Das C; Kulkarni S; Ghate M; Godbole S
    PLoS One; 2023; 18(5):e0285942. PubMed ID: 37200292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya.
    Bwana P; Ageng'o J; Mwau M
    PLoS One; 2019; 14(3):e0213865. PubMed ID: 30901343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
    Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
    AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing.
    Peter T; Zeh C; Katz Z; Elbireer A; Alemayehu B; Vojnov L; Costa A; Doi N; Jani I
    J Int AIDS Soc; 2017 Nov; 20 Suppl 7(Suppl 7):. PubMed ID: 29130601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near Point-of-Care HIV Viral Load: Targeted Testing at Large Facilities.
    Ganesh P; Heller T; Chione B; Gumulira J; Gugsa S; Khan S; McGovern S; Nhlema A; Nkhoma L; Sacks JA; Trapence C; Tweya H; Ehrenkranz P; Phiri S
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):258-263. PubMed ID: 33136821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral load testing among women on 'option B+' in Mazowe, Zimbabwe: How well are we doing?
    Nyakura J; Shewade HD; Ade S; Mushavi A; Mukungunugwa SH; Chimwaza A; Owiti P; Senkoro M; Mugurungi O
    PLoS One; 2019; 14(12):e0225476. PubMed ID: 31794561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using queueing models as a decision support tool in allocating point-of-care HIV viral load testing machines in Kisumu County, Kenya.
    Wang Y; Wagner AD; Liu S; Kingwara L; Oyaro P; Brown E; Karauki E; Yongo N; Bowen N; Kiiru J; Hassan S; Patel R
    Health Policy Plan; 2024 Jan; 39(1):44-55. PubMed ID: 37949109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Time to Repeat Viral Load Testing Among Unsuppressed Adolescents and Young Adults Living With HIV in Kenya.
    Mugo C; Wilson KS; Onyango A; Njuguna IN; Mburu CW; Richardson BA; Oyiengo L; Inwani I; John-Stewart G; Wamalwa DC; Kohler PK
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):606-611. PubMed ID: 32897936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis.
    Opollo VS; Nikuze A; Ben-Farhat J; Anyango E; Humwa F; Oyaro B; Wanjala S; Omwoyo W; Majiwa M; Akelo V; Zeh C; Maman D
    PLoS One; 2018; 13(12):e0209778. PubMed ID: 30589900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integration of tuberculosis and HIV testing on GeneXpert can substantially improve access and same-day diagnosis and benefit tuberculosis programmes: A diagnostic network optimization analysis in Zambia.
    Girdwood S; Pandey M; Machila T; Warrier R; Gautam J; Mukumbwa-Mwenechanya M; Benade M; Nichols K; Shibemba L; Mwewa J; Mzyece J; Lungu P; Albert H; Nichols B; Choonga P
    PLOS Glob Public Health; 2023; 3(1):e0001179. PubMed ID: 36963019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
    Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
    J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya.
    Bwana P; Ageng'o J; Danda J; Mbugua J; Handa A; Mwau M
    J Clin Virol; 2019 Dec; 121():104202. PubMed ID: 31715524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.